COVID19: Although Biden Says the Pandemic Is Over, You May Still Want to Know About Nasal Irrigation, Which Reduced Deaths and Hospitalization

October 23, 2022 · 7:00 AM

Photo by Engin Akyurt on Pexels.com

From ScienceDaily:

Starting twice daily flushing of the mucus-lined nasal cavity with a mild saline solution immediately after testing positive for COVID-19 can significantly reduce hospitalization and death, investigators report.

They say the technique that can be used at home by mixing a half teaspoon each of salt and baking soda in a cup of boiled or distilled water then putting it into a sinus rinse bottle is a safe, effective and inexpensive way to reduce the risk of severe illness and death from coronavirus infection that could

1 min read

Why Cano Health’s Shares Dropped 27.9% in December

What happened

Shares of Cano Health (CANO 3.57%) fell 27.9% in December, according to data provided by S&P Global Market Intelligence. The stock closed November at $1.90 a share but fell as low as $1.01 on Dec. 28. The stock has a 52-week low of $0.9801 and a 52-week high of $9.75. The downward move followed a 46.9% drop in November.

So what

Investors took a closer look at the healthcare company’s financials after the Third Point hedge fund pulled out its investment from Cano, citing the company’s illiquidity. Cano focuses on senior primary healthcare and has 151 facilities

2 min read

COVID: 2022 ends with the risk of new variant, warn experts

As the world enters a new year, many public health and infectious disease experts predict that monitoring for new coronavirus variants will be an increasingly important part of Covid-19 mitigation efforts — and some are turning their attention to a surge in cases in China.

Subvariants of the Omicron coronavirus variant continue to circulate globally, and “we’re seeing Omicron do what viruses do, which is it picks up mutations along the way that helps it evade a little bit of immunity that’s induced by previous infection or vaccination,” said Andrew Pekosz, a microbiologist and immunologist at the Johns Hopkins Bloomberg

8 min read